Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record. Visible content such as study details and linked documents is no longer accessible on this page.SummaryDifference24%

- Check32 days agoChange DetectedThis change removes the phrase 'Multiple myeloma' from the study page and deletes the related topics section including the MedlinePlus Genetics link.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a backend/template update to the study page. The visible content remains unchanged.SummaryDifference0.0%

- Check67 days agoChange DetectedThe study page now includes the disease term Multiple myeloma and a related topics link to MedlinePlus Genetics, improving context and discoverability. The revision tag has been updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check74 days agoChange DetectedA Study Documents section was added with links to PDFs (Study Protocol, SAP) and information about IPD sharing. It also includes an IPD Sharing URL and related resources, expanding access to documentation and data-sharing details for researchers and interested readers.SummaryDifference94%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.